National Science Foundation

Students looking to work in state-of-the-art computer science and engineering facilities should look no further than the University of Nebraska at Omaha. UNO is a leader Bioinformatics, Computer Science and Management Information Systems programs. But UNO is not merely a four-year state university focused on science. With approximately 200 academic programs, this school offers an intimate atmosphere in a thriving city with numerous employment options for future graduates. The University of Nebraska at Omaha implements the Four-Year Guarantee resolution, meaning that the university will design a curriculum dedicated to permitting students to graduate as quickly as possible. UNO has a non-refundable $45 application fee for all applicants. The admissions requirements are based on core course prerequisites and performance requirements. The performance requirements for UNO admissions are a rank in the upper half of your graduating high school class and an ACT score of 20 or higher. The core course requirements are similar to the core requirements of other four-year colleges. UNO offers several types of financial aid to ease the cost of tuition. Not only do they have federal and state programs, but the school also offers scholarships, work-study programs and loans.

Epicrop Technologies, Inc. is a biotechnology company based in Lincoln, Nebraska, founded in 2013. The company specializes in developing innovative epigenetic technology aimed at enhancing crop yields and crop development. Epicrop's technology focuses on improving abiotic stress tolerance across all plant species, providing farmers with the tools to increase productivity while maintaining lower crop prices. In addition to its core technology, Epicrop also offers support services that assist in optimizing crop production, thereby contributing to sustainable agricultural practices.

DTN is a provider of real-time business intelligence that serves various sectors, including agriculture, energy, weather, financial analytics, and transportation. Founded in 1984 and headquartered in Omaha, Nebraska, with additional offices across several states, DTN delivers operationally-critical insights through analytics and machine learning. The company utilizes the Internet, satellite, and data feed connections to provide news, information, and analysis, empowering clients to make informed business decisions. Its services cater to industries such as commodities trading, public safety, aviation, construction, and turf management, enabling organizations with complex supply chains to navigate challenges effectively. DTN operates as a subsidiary of Telvent Git S.A.

Ground Fluor Pharmaceuticals, Inc. is a biomedical company based in Lincoln, Nebraska, specializing in fluorine chemistry solutions for positron emission tomography (PET) imaging. Established in 2012, the company focuses on developing and providing imaging agents that aid in the diagnosis and management of diseases. Ground Fluor Pharmaceuticals has pioneered new chemistry technologies that simplify complex and costly fluorine syntheses, enhancing the efficiency and cost-effectiveness of producing PET imaging agents. Their proprietary processes and intermediate chemicals, developed from research at the University of Nebraska and Massachusetts General Hospital, allow for higher yields and potency in fluorine synthesis. Additionally, the company supports other firms in manufacturing their own PET imaging agents, further advancing the field of medical imaging.

Ground Fluor Pharmaceuticals, Inc. is a biomedical company based in Lincoln, Nebraska, specializing in fluorine chemistry solutions for positron emission tomography (PET) imaging. Established in 2012, the company focuses on developing and providing imaging agents that aid in the diagnosis and management of diseases. Ground Fluor Pharmaceuticals has pioneered new chemistry technologies that simplify complex and costly fluorine syntheses, enhancing the efficiency and cost-effectiveness of producing PET imaging agents. Their proprietary processes and intermediate chemicals, developed from research at the University of Nebraska and Massachusetts General Hospital, allow for higher yields and potency in fluorine synthesis. Additionally, the company supports other firms in manufacturing their own PET imaging agents, further advancing the field of medical imaging.